Here’s why I’d buy into the Taylor Wimpey share price today

Despite 2019’s gains, the Taylor Wimpey plc (LON: TW) share price still looks very attractive to me.

| More on:

The content of this article was relevant at the time of publishing. Circumstances change continuously and caution should therefore be exercised when relying upon any content contained within this article.

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More.

RISK WARNING: should you invest, the value of your investment may rise or fall and your capital is at risk. Before investing, your individual circumstances should be assessed. Consider taking independent financial advice. The Motley Fool believes in building wealth through long-term investing and so we do not promote or encourage high-risk activities including day trading, CFDs, spread betting, cryptocurrencies, and forex. Where we promote an affiliate partner’s brokerage products, these are focused on the trading of readily releasable securities.

I really don’t understand why Taylor Wimpey (LSE: TW) shares are on such a low valuation, and are so volatile. On the valuation front, after a 5% morning drop on first-half results day Wednesday, the shares are trading on a prospective P/E of around 8.3. That’s not for a company that’s struggling, or one that’s laden with debt.

Cheap?

Sure, there’s a small drop in EPS on the cards this year. And I think we’re very likely in for a relatively flat couple of years after that. But it’s been expected for some time, and there’s nothing wrong with that. And Taylor Wimpey is still generating lots of cash and paying handsome dividends.

The first six months of the year saw the firm complete 6,541 new homes, up slightly from 6,497 a year previously, though operating profit dropped from £344m to £312m, due to high build costs and a changed geographic mix. The company ended the period with net cash of £392m — that’s down from £525m, but cash can be lumpy over the short term because of the timing of land payments and of investment in work in progress.

Big dividends

Including special dividends, shareholders are expected to pocket 18.3p per share in 2019, and 18.6p in 2020 — for total yields of 11%.

Chief executive Pete Redfern told us that “conditions for the housing market continue to be supportive with good affordability and access to finance,” and said full-year results should be in line with expectations.

Brexit or not, the UK’s chronic housing shortage won’t be ending soon. And cooling property prices shouldn’t really be a problem for housebuilders, which still make their margins whether land and house prices are rising or falling. So Taylor Wimpey is firmly on my income share buy list.

Disliked

If Taylor Wimpey shares are out of favour right now, those of estate agent Countrywide (LSE: CWD) appear to be positively despised. Earnings have collapsed, leading to a five-year share price crash of 98%. But it’s been ticking up modestly since a low point in June, and Wednesday’s first-half results suggest Countrywide’s recovery plan is starting to deliver.

Total income dropped by 4% to £291m, largely in line with expectations. But the firm recorded an operating profit of £10m, from a loss of £3.3m a year ago. And EPS turned modestly positive, at 0.3p from a prior loss of 2.7p.

Speaking of “the increased momentum in sales of complementary services and cost actions taken in the first half,” Countrywide expects the second half to show stronger progress.

Downside

But there’s still significant net debt, at £90m, which is 3.4 times adjusted EBITDA. That’s a major concern for me, and though the firm says its new covenants with lenders should help it through, I fear any faltering of the current recovery progress, or other hurdles that might be encountered along the path, could plunge the company back into crisis.

Forecasts suggest 2020 will bring an acceleration of EPS. Admittedly, it would still be tiny compared to previous years, but it would bring the P/E down to 10, and further recovery in 2021 might even see that valuation fall considerably lower. So is Countrywide an attractive recovery play right now?

Possibly, but the risks as too high for me. I’d need to see firm recovery progress and some debt reduction first.

RISK WARNING: should you invest, the value of your investment may rise or fall and your capital is at risk. Before investing, your individual circumstances should be assessed. Consider taking independent financial advice. The Motley Fool believes in building wealth through long-term investing and so we do not promote or encourage high-risk activities including day trading, CFDs, spread betting, cryptocurrencies, and forex. Where we promote an affiliate partner’s brokerage products, these are focused on the trading of readily releasable securities.

Alan Oscroft has no position in any of the shares mentioned. The Motley Fool UK has no position in any of the shares mentioned. Views expressed on the companies mentioned in this article are those of the writer and therefore may differ from the official recommendations we make in our subscription services such as Share Advisor, Hidden Winners and Pro. Here at The Motley Fool we believe that considering a diverse range of insights makes us better investors.

More on Investing Articles

Investing Articles

Publish Test

Lorem ipsum dolor sit amet, consectetur adipiscing elit. Sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut…

Read more »

Investing Articles

JP P-Press Update Test

Read more »

Investing Articles

JP Test as Author

Test content.

Read more »

Investing Articles

KM Test Post 2

Read more »

Investing Articles

JP Test PP Status

Test content. Test headline

Read more »

Investing Articles

KM Test Post

This is my content.

Read more »

Investing Articles

JP Tag Test

Read more »

Investing Articles

Testing testing one two three

Sample paragraph here, testing, test duplicate

Read more »